Cravens & Co Advisors, LLC
- SEC CIK
- 0001966116
- Latest filing
- Aug 12, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Cravens & Co Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −9,117−100.0% | Sold out | Holders |
| Q1 2026 | 9,117 | $936.0K | 0.6% | +555+6.5% | Added | Holders |
| Q4 2025 | 8,562 | $1.06M | 0.7% | −578−6.3% | Reduced | Holders |
| Q3 2025 | 9,140 | $1.22M | 0.8% | +515+6.0% | Added | Holders |
| Q2 2025 | 8,625 | $1.17M | 0.9% | −21−0.2% | Reduced | Holders |
| Q1 2025 | 8,646 | $1.15M | 0.9% | −293−3.3% | Reduced | Holders |
| Q4 2024 | 8,939 | $1.01M | 0.8% | +145+1.6% | Added | Holders |
| Q3 2024 | 8,794 | $1.00M | 0.8% | −886−9.2% | Reduced | Holders |
| Q2 2024 | 9,680 | $1.01M | 0.7% | +2,427+33.5% | Added | Holders |
| Q1 2024 | 7,253 | $824.4K | 0.7% | +344+5.0% | Added | Holders |
| Q4 2023 | 6,909 | $760.5K | 0.7% | −296−4.1% | Reduced | Holders |
| Q3 2023 | 7,205 | $697.8K | 0.7% | +118+1.7% | Added | Holders |
| Q2 2023 | 7,087 | $772.6K | 0.7% | −25−0.4% | Reduced | Holders |
| Q1 2023 | 7,112 | $720.2K | 0.7% | +170+2.4% | Added | Holders |
| Q4 2022 | 6,942 | $762.2K | 0.7% | – | No prior filing | Holders |